Indivior wins preliminary injunction against generic rival

(Reuters) – A U.S. court has granted Indivior a preliminary injunction blocking India’s Dr. Reddy’s Laboratories from selling cut-price versions of the British drugmaker’s best-selling opioid addiction treatment in the United States, Indivior said on Friday.

Indivior, a maker of opioid addiction treatments spun-off from Reckitt Benckiser in 2014, has been involved in a number of legal battles with generic drugmakers over their versions of its Suboxone Film .

Indivior got a temporary restraining order against Dr.Reddy’s in June, but the British firm saw the impact from a generic in…

Read More Here

Be the first to comment on "Indivior wins preliminary injunction against generic rival"

Leave a comment

Your email address will not be published.